Targeting micrornas for metabolic disorders

MA40463AUndetermined Publication Date: 2017-06-14REGULUS THERAPEUTICS INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA40463
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2015-04-06
Filing Date: 2015-08-06
Publication Date: 2017-06-14

Application Information

Patent Timeline

06 Apr 2015

Priority

06 Aug 2015

Application

MA40463

14 Jun 2017

Publication

MA40463A

IPC: A61K31/712; C07H21/00; C12N15/113

CPC: A61K31/7088; C12N15/113; C12N2310/113; C12N2310/345; C12N2310/346; C12N2310/351; C12N2310/315; C12N2310/3231

Inventors: BARTEL David; BHAT Balkrishen

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

Described herein are compounds comprising modified oligonucleotides that are complementary to mir-103 and / or mir-107 and methods of treating diseases and disorders using the compounds.

Need to check novelty before this filing date? Find Prior Art